Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from CLX

Clorox Claims Cognizant Handed Credentials To Hacker, Ignored Security Protocols (UPDATED)

Editor’s Note: The story has been updated with statement from Cognizant

Benzinga

Clorox Earnings Preview: What to Expect

Clorox is gearing up to release its fourth-quarter results in the upcoming week, and analysts expect a solid double-digit growth in earnings.

Barchart

Clorox Stock: Is CLX Underperforming the Consumer Staples Sector?

As Clorox has underperformed its broader sector recently, analysts remain cautious about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Le Mans 24 Hours: Toyota tops second practice after Kubica Ferrari loses best time

Toyota ended up fastest in second free practice for the Le Mans 24 Hours after the customer AF Corse 499P Le Mans Hypercar lost its best time for pitlane speeding.

Motorsport

Clorox Stock: Analyst Estimates & Ratings

Clorox has underperformed the broader market over the past year, and analysts remain skeptical about the stock’s prospects.

Barchart

What You Need To Know Ahead of Clorox's Earnings Release

Clorox is poised to announce its third-quarter results next month, and analysts predict a single-digit dip in the company’s bottom-line figure.

Barchart

Is Clorox Stock Underperforming the Dow?

Clorox has notably underperformed the Dow over the past year and analysts remain cautious about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Prototype Winter Series: Soufi and Konrad become two-time champions

Danny Soufi and Konrad Motorsport confirmed themselves as the 2025 Prototype Winter Series champions, with a stellar sweep of the final races of the season.

Autosport

Prototype Winter Series: Soufi and Horr share the victories at Aragon

The 2025 Prototype Winter Series will be decided at the final event of the season, after an Aragon weekend where Konrad Motorsport’s Danny Soufi was finally beaten to the chequered flag.

Autosport

Do Wall Street Analysts Like Clorox Stock?

Clorox has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Barchart

What to Expect From Clorox’s Next Quarterly Earnings Report

Clorox will release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip.

Barchart

Is Clorox Company Stock Underperforming the Nasdaq?

Clorox Company has recently underperformed the Nasdaq Composite, and Wall Street analysts are expressing a neutral perspective on its outlook.

Barchart

Clorox Stock Outlook: Is Wall Street Bullish or Bearish?

Clorox has underperformed the broader market over the past year, prompting analysts to maintain a cautious outlook on the stock’s future prospects.

Barchart

What to Expect From Clorox's Q1 2025 Earnings Report

With Clorox gearing up to release its first-quarter earnings later this month, analysts expect a massive triple-digit surge in earnings.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Clorox Company Stock Outperforming the S&P 500?

Clorox Company has recently outperformed the S&P 500, but Wall Street analysts have a bleak outlook on its future.

StockNews.com

3 Dividend Aristocrats With Tech-Like Growth

During economic uncertainty, dividend aristocrat stocks are a prudent choice as they provide stable income and shield against inflation. Therefore, it could be wise to consider buying dividend aristocrat stocks like General Dynamics (GD), Clorox (CLX), and Stanley Black & Decker (SWK), which have significant growth potential. Keep reading.

Barchart

Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink?

Clorox has lagged the broader market over the past year, and analysts are cautious about the stock’s potential.

Barchart

Here's What to Expect From Clorox's Next Earnings Report

Clorox is poised to announce its fourth-quarter results next month, and analysts forecast a single-digit decline in the company’s bottom-line figure.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Top 3 Defensive Stocks for Stability in a Volatile Market

With the Fed’s decision and presidential election looming, market jitters might affect stock performances. Amid this backdrop, investors could consider buying defensive stocks Procter & Gamble (PG), Coca-Cola (KO), and Clorox (CLX) for stability in a volatile market. Read on….

Barchart

Heads Up! These 3 Dividend Aristocrats Could Fly High in 2024.

By comparing a stock's year-opening price with its current trading price, it can help determine if a stock is on the move.

Barchart

Is This Dividend Aristocrat a Buy After Earnings?

Clorox stock is down 42% from all-time highs and offers a dividend yield of almost 4%. Is this beaten-down dividend stock a good buy right now?

Investors Business Daily

Dow Jones Dips; Elon Musk Says This Amid SEC Lawsuit; Fed Official Speaks Out On Yields

The Dow Jones rallied off lows after a Federal Reserve official spoke. The SEC sued Tesla CEO Elon Musk. The jobs report looms.

StockNews.com

2 Consumer Good Stocks to Buy Today, 1 Worth Watching for Growth

The consumer sector’s prospects look bright, fueled by inelastic demand and steady consumer spending. Hence, it could be wise for investors to buy fundamentally strong consumer stocks Colgate-Palmolive (CL) and Clorox (CLX). However, Peloton Interactive (PTON) might be best added to your watchlist. Keep reading.

Barchart

3 100% Buy Rated Dividend Elites To Check Out Today

Is This the Best Rating Metric for You? A Closer Look at Barchart Opinion Rating

Benzinga

Clorox (CLX) Readies For Q4 Earnings: What's In The Cards?

The Clorox Company CLX is likely to register top-line growth when it reports fourth-quarter fiscal 2022 earnings on Aug 3. The Zacks Consensus Estimate for quarterly revenues is pegged at $1,856 million, suggesting a rise of around 3% from the prior-year quarter's reported figure.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.